Clinical Trials Browser

Phase 1 × Enrolling by invitation × Lymphoid × Clear all

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Phase 1 Enrolling by invitation

15 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06827782 2025-08-15

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Phase 1 Enrolling by invitation

42 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT04488354 2025-01-10

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Phase 1 Enrolling by invitation

36 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

Clinical Trials

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T